Cargando…
Targeted Therapies in Sarcomas: Challenging the Challenge
Sarcomas are a heterogeneous group of mesenchymal malignancies that very often lead to death. Nowadays, chemotherapy is the only available treatment for most sarcomas but there are few active drugs and clinical results still remain very poor. Thus, there is an imperious need to find new therapeutic...
Autores principales: | Martín Liberal, Juan, Lagares-Tena, Laura, Sáinz-Jaspeado, Miguel, Mateo-Lozano, Silvia, García del Muro, Xavier, Tirado, Oscar M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372278/ https://www.ncbi.nlm.nih.gov/pubmed/22701332 http://dx.doi.org/10.1155/2012/626094 |
Ejemplares similares
-
Caveolin-1 in sarcomas: friend or foe?
por: Sáinz-Jaspeado, Miguel, et al.
Publicado: (2011) -
EphA2-Induced Angiogenesis in Ewing Sarcoma Cells Works through bFGF Production and Is Dependent on Caveolin-1
por: Sáinz-Jaspeado, Miguel, et al.
Publicado: (2013) -
Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway
por: Lagares-Tena, Laura, et al.
Publicado: (2016) -
The Importance of Being Dead: Cell Death Mechanisms Assessment in Anti-Sarcoma Therapy
por: Rello-Varona, Santiago, et al.
Publicado: (2015) -
Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth
por: Huertas-Martínez, Juan, et al.
Publicado: (2014)